InvestorsHub Logo
Followers 46
Posts 4446
Boards Moderated 0
Alias Born 07/26/2010

Re: investorsa post# 297

Monday, 08/18/2014 11:30:12 AM

Monday, August 18, 2014 11:30:12 AM

Post# of 1361
SIGA (NASDAQ:SIGA) is an anti-infective company headquartered in New York is working closely with federal agencies to develop a range of compounds that target diseases that could be used as bioweapons, such as smallpox. The company has one compound that it is developing to target filo-viruses such as Ebola.

SIGA uses analytical tools to evaluate the bacterial and viral genomes to find new targets against these bugs. The company is currently testing three different experimental drugs. SIGA’s compounds work by trying to prevent the Ebola virus from entering host cells. This would block the ability of the virus to replicate.

http://www.forbes.com/sites/scottgottlieb/2014/08/18/as-the-ebola-outbreak-expands-these-experimental-drugs-could-see-action/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SIGA News